INmune Bio Inc (INMB)
8.28
-0.21
(-2.47%)
USD |
NASDAQ |
Jun 17, 16:00
8.28
0.00 (0.00%)
Pre-Market: 09:12
INmune Bio Free Cash Flow: -18.32M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -18.32M |
| December 31, 2023 | -11.98M |
| September 30, 2023 | -14.27M |
| June 30, 2023 | -13.38M |
| March 31, 2023 | -14.96M |
| December 31, 2022 | -22.69M |
| September 30, 2022 | -26.77M |
| June 30, 2022 | -31.33M |
| March 31, 2022 | -32.28M |
| December 31, 2021 | -28.50M |
| September 30, 2021 | -21.12M |
| Date | Value |
|---|---|
| June 30, 2021 | -16.89M |
| March 31, 2021 | -13.00M |
| December 31, 2020 | -8.943M |
| September 30, 2020 | -6.984M |
| June 30, 2020 | -5.232M |
| March 31, 2020 | -5.032M |
| December 31, 2019 | -5.385M |
| September 30, 2019 | -5.414M |
| June 30, 2019 | -3.918M |
| March 31, 2019 | -3.118M |
| December 31, 2018 | -2.059M |
Free Cash Flow Range, Past 5 Years
-32.28M
Minimum
Mar 2022
-3.918M
Maximum
Jun 2019
-15.32M
Average
-13.83M
Median
Free Cash Flow Benchmarks
| AVITA Medical Inc | -52.18M |
| Dare Bioscience Inc | -30.19M |
| Zevra Therapeutics Inc | -45.66M |
| Xeris Biopharma Holdings Inc | -43.38M |
| Kodiak Sciences Inc | -175.76M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.476M |
| Cash from Financing (Quarterly) | -2.50M |
| Free Cash Flow Per Share (Quarterly) | -0.4147 |
| Free Cash Flow to Equity (Quarterly) | -5.01M |
| Free Cash Flow Yield | -12.29% |